1 |
CHEN S Z, HUANG M Y, ZHANG L M, et al. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis[J]. Comput Struct Biotechnol J, 2024, 23: 369-383.
|
2 |
AGIRMAN G, YU K B, HSIAO E Y. Signaling inflammation across the gut-brain axis[J]. Science, 2021, 374(6571): 1087-1092.
|
3 |
SCHROEDER H T, DE LEMOS MULLER C H, HECK T G, et al. Heat shock response during the resolution of inflammation and its progressive suppression in chronic-degenerative inflammatory diseases[J]. Cell Stress Chaperones, 2024, 29(1): 116-142.
|
4 |
FURMAN D, CAMPISI J, VERDIN E, et al. Chronic inflammation in the etiology of disease across the life span[J]. Nat Med, 2019, 25(12): 1822-1832.
|
5 |
YING W, FU W X, LEE Y S, et al. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities[J]. Nat Rev Endocrinol, 2020, 16(2): 81-90.
|
6 |
LI D J, TONG J, LI Y H, et al. Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a β-arrestin-1 dependent manner[J]. J Pineal Res, 2019, 67(4): e12611.
|
7 |
DAWED A Y, MARI A, BROWN A, et al. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials[J]. Lancet Diabetes Endocrinol, 2023, 11(1): 33-41.
|
8 |
DEWIRE S M, AHN S, LEFKOWITZ R J, et al. β-arrestins and cell signaling[J]. Annu Rev Physiol, 2007, 69: 483-510.
|
9 |
LOVGREN A K, KOVACS J J, XIE T, et al. β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix[J]. Sci Transl Med, 2011, 3(74): 74ra23.
|
10 |
CHOI Y J, KIM J E, LEE S J, et al. Promotion of the inflammatory response in mid colon of complement component 3 knockout mice[J]. Sci Rep, 2022, 12(1): 1700.
|
11 |
张泉, 张梅. β-arrestin1在炎-癌转化中的研究进展[J]. 现代肿瘤医学, 2022, 30(15): 2864-2867.
|
|
ZHANG Q, ZHANG M. Research progress of β-arrestin1 in inflammation-induced carcinogenesis[J]. Journal of Modern Oncology, 2022, 30(15): 2864-2867.
|
12 |
MAFI A, KIM S K, GODDARD WA 3rd. The mechanism for ligand activation of the GPCR-G protein complex[J]. Proc Natl Acad Sci U S A, 2022, 119(18): e2110085119.
|
13 |
LEFKOWITZ R J, SHENOY S K. Transduction of receptor signals by β-arrestins[J]. Science, 2005, 308(5721): 512-517.
|
14 |
KO M J, CHIANG T, MUKADAM A A, et al. β-arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice[J]. Sci Signal, 2021, 14(694): eaba0245.
|
15 |
ZHANG Z, ZHONG X H, XIAO Y P, et al. MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation[J]. Oncol Rep, 2019, 41(1): 619-629.
|
16 |
LI J, WEI B, GUO A, et al. Deficiency of β-arrestin1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation[J]. Proc Natl Acad Sci U S A, 2013, 110(18): 7395-7400.
|
17 |
XU X, LEI Y M, CHEN L J, et al. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target[J]. J Exp Clin Cancer Res, 2021, 40(1): 253.
|
18 |
RANJAN R, GUPTA P, SHUKLA A K. GPCR signaling: β-arrestins kiss and remember[J]. Curr Biol, 2016, 26(7): R285-R288.
|
19 |
OAKLEY R H, LAPORTE S A, HOLT J A, et al. Differential affinities of visual arrestin, β arrestin1, and β arrestin2 for G protein-coupled receptors delineate two major classes of receptors[J]. J Biol Chem, 2000, 275(22): 17201-17210.
|
20 |
CHEN K, ZHANG C H, LIN S L, et al. Tail engagement of arrestin at the glucagon receptor[J]. Nature, 2023, 620(7975): 904-910.
|
21 |
SUN L N, SU Y H, JIAO A J, et al. T cells in health and disease[J]. Signal Transduct Target Ther, 2023, 8(1): 235.
|
22 |
陈燕华, 蒋光洁, 郭维, 等. Arrb1基因敲除对小鼠T淋巴细胞发育的影响[J]. 中国细胞生物学学报, 2018, 40(3): 373-380.
|
|
CHEN Y H, JIANG G J, GUO W, et al. Effects of Arrb1 knockout on the development of mice T lymphocytes[J]. Chinese Journal of Cell Biology, 2018, 40(3): 373-380.
|
23 |
GUREVICH V V, GUREVICH E V. Arrestin makes T cells stop and become active[J]. EMBO J, 2014, 33(6): 531-533.
|
24 |
BJØRGO E, TASKÉN K. Novel mechanism of signaling by CD28[J]. Immunol Lett, 2010, 129(1): 1-6.
|
25 |
ABRAHAMSEN H, BAILLIE G, NGAI J, et al. TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling[J]. J Immunol, 2004, 173(8): 4847-4858.
|
26 |
SHI Y F, FENG Y, KANG J H, et al. Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1[J]. Nat Immunol, 2007, 8(8): 817-824.
|
27 |
GÓMEZ-MELERO S, GARCÍA-MACEIRA F I, GARCÍA-MACEIRA T, et al. Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin[J]. BMC Biotechnol, 2021, 21(1): 41.
|
28 |
KUMAR R, THEISS A L, VENUPRASAD K. RORγt protein modifications and IL-17-mediated inflammation[J]. Trends Immunol, 2021, 42(11): 1037-1050.
|
29 |
CAO Y P, HE W, LI X P, et al. Rosiglitazone protects against acetaminophen-induced acute liver injury by inhibiting multiple endoplasmic reticulum stress pathways[J]. Biomed Res Int, 2022, 2022: 6098592.
|
30 |
LEI Y M, WAN S Z, LIU H L, et al. ARRB1 suppresses the activation of hepatic macrophages via modulating endoplasmic reticulum stress in lipopolysaccharide-induced acute liver injury[J]. Cell Death Discov, 2021, 7(1): 223.
|
31 |
WU B S, ZHOU Q, HE Z Q, et al. Protective effect of the Abelmoschus manihot flower extract on DSS-induced ulcerative colitis in mice[J]. Evid Based Complement Alternat Med, 2021, 2021: 7422792.
|
32 |
KANG S, NARAZAKI M, METWALLY H, et al. Historical overview of the interleukin-6 family cytokine[J]. J Exp Med, 2020, 217(5): e20190347.
|
33 |
FANG Y Q, JIANG Q L, LI S S, et al. Opposing functions of β-arrestin 1 and 2 in Parkinson's disease via microglia inflammation and Nprl3[J]. Cell Death Differ, 2021, 28(6): 1822-1836.
|
34 |
ZHANG Q, XU N, HU X, et al. Anti-colitic effects of Physalin B on dextran sodium sulfate-induced BALB/c mice by suppressing multiple inflammatory signaling pathways[J]. J Ethnopharmacol, 2020, 259: 112956.
|
35 |
MAO K, CHEN S, WANG Y, et al. β-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes[J]. J Immunol, 2015, 194(4): 1867-1873.
|
36 |
YANG Y D, GUO Y W, TAN S W, et al. β-arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling[J]. Nat Commun, 2015, 6: 7369.
|
37 |
ZHANG Z C, XU X L, TIAN W F, et al. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation[J]. J Hepatol, 2020, 72(5): 976-989.
|
38 |
ZHUANG L N, HU W X, XIN S M, et al. β-arrestin-1 protein represses adipogenesis and inflammatory responses through its interaction with peroxisome proliferator-activated receptor-γ (PPARγ)[J]. J Biol Chem, 2011, 286(32): 28403-28413.
|
39 |
TAO L, LIN X Y, TAN S W, et al. β-arrestin1 alleviates acute pancreatitis via repression of NF-κBp65 activation[J]. J Gastroenterol Hepatol, 2019, 34(1): 284-292.
|
40 |
WITHEROW D S, GARRISON T R, MILLER W E, et al. β-arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα[J]. Proc Natl Acad Sci U S A, 2004, 101(23): 8603-8607.
|
41 |
ZHENG F, XIAO F, YUAN Q H, et al. Penehyclidine hydrochloride decreases pulmonary microvascular endothelial inflammatory injury through a β-arrestin-1-dependent mechanism[J]. Inflammation, 2018, 41(5): 1610-1620.
|
42 |
FAN H K, LUTTRELL L M, TEMPEL G E, et al. β-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression[J]. Mol Immunol, 2007, 44(12): 3092-3099.
|
43 |
WANG M W, YANG Z, CHEN X, et al. Activation of PTH1R alleviates epididymitis and orchitis through Gq and β-arrestin-1 pathways[J]. Proc Natl Acad Sci U S A, 2021, 118(45): e2107363118.
|
44 |
SHU Y, WANG Y, LV W Q, et al. ARRB1-promoted NOTCH1 degradation is suppressed by oncomiR miR-223 in T-cell acute lymphoblastic leukemia[J]. Cancer Res, 2020, 80(5): 988-998.
|